nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Cost Effectiveness of Moderate to Severe Psoriasis Therapy with Etanercept and Ustekinumab in the United States
|
Villacorta, Reginald |
|
2013 |
31 |
9 |
p. 823-839 |
artikel |
2 |
Costs of Parkinson’s Disease in a Privately Insured Population
|
Johnson, Scott J. |
|
2013 |
31 |
9 |
p. 799-806 |
artikel |
3 |
Cost–Utility Analysis of Deferiprone for the Treatment of β-Thalassaemia Patients with Chronic Iron Overload: A UK Perspective
|
Bentley, Anthony |
|
2013 |
31 |
9 |
p. 807-822 |
artikel |
4 |
Navigating Time and Uncertainty in Health Technology Appraisal: Would a Map Help?
|
McCabe, Christopher |
|
2013 |
31 |
9 |
p. 731-737 |
artikel |
5 |
Protease Inhibitors for Hepatitis C: Economic Implications
|
Turner, Stuart J. |
|
2013 |
31 |
9 |
p. 739-751 |
artikel |
6 |
Smoking Cessation Treatment and Outcomes Patterns Simulation: A New Framework for Evaluating the Potential Health and Economic Impact of Smoking Cessation Interventions
|
Getsios, Denis |
|
2013 |
31 |
9 |
p. 767-780 |
artikel |
7 |
The Economic Burden of Toxicities Associated with Cancer Treatment: Review of the Literature and Analysis of Nausea and Vomiting, Diarrhoea, Oral Mucositis and Fatigue
|
Carlotto, Alan |
|
2013 |
31 |
9 |
p. 753-766 |
artikel |
8 |
Unravelling Drug Reimbursement Outcomes: A Comparative Study of the Role of Pharmacoeconomic Evidence in Dutch and Swedish Reimbursement Decision Making
|
Franken, Margreet |
|
2013 |
31 |
9 |
p. 781-797 |
artikel |